Daiwa Securities Group Inc. Bridge Bio Pharma, Inc. Transaction History
Daiwa Securities Group Inc.
- $27.1 Billion
- Q2 2025
A detailed history of Daiwa Securities Group Inc. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 664 shares of BBIO stock, worth $36,845. This represents 0.0% of its overall portfolio holdings.
Number of Shares
664
Previous 624
6.41%
Holding current value
$36,845
Previous $22,000
31.82%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding BBIO
# of Institutions
409Shares Held
187MCall Options Held
11.3MPut Options Held
2.2M-
Viking Global Investors LP18.6MShares$1.03 Billion2.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.5MShares$915 Million0.01% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY13.3MShares$736 Million22.63% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$691 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X09.28MShares$515 Million0.21% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $8.23B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...